日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Robotic assistance during cochlear implantation: the rationale for consistent, controlled speed of electrode array insertion

机器人辅助人工耳蜗植入术:实现电极阵列插入速度一致且可控的理论依据

Kashani, Rustin G; Henslee, Allan; Nelson, Rick F; Hansen, Marlan R

Combining Intraoperative Electrocochleography with Robotics-Assisted Electrode Array Insertion

将术中耳蜗电图与机器人辅助电极阵列植入相结合

Kashani, Rustin G; Kocharyan, Armine; Bennion, Douglas M; Scheperle, Rachel A; Etler, Christine; Oleson, Jacob; Dunn, Camille C; Claussen, Alexander D; Gantz, Bruce J; Hansen, Marlan R

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

西地尼布联合化疗治疗复发性铂敏感卵巢癌女性患者(ICON6):一项 III 期随机试验的总生存期结果

Ledermann, J A; Embleton-Thirsk, A C; Perren, T J; Jayson, G C; Rustin, G J S; Kaye, S B; Hirte, H; Oza, A; Vaughan, M; Friedlander, M; González-Martín, A; Deane, E; Popoola, B; Farrelly, L; Swart, A M; Kaplan, R S; Parmar, M K B

Shortwave infrared otoscopy for diagnosis of middle ear effusions: a machine-learning-based approach

短波红外耳镜在诊断中耳积液中的应用:一种基于机器学习的方法

Kashani, Rustin G; Młyńczak, Marcel C; Zarabanda, David; Solis-Pazmino, Paola; Huland, David M; Ahmad, Iram N; Singh, Surya P; Valdez, Tulio A

Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?

CA125 在监测铂类耐药性卵巢癌患者中是否有用?

Rustin, G J S; Hall, M R

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

一项多中心、随机对照试验,比较单药卡铂一线化疗方案中固定剂量与患者体内剂量递增的疗效:一项由SGCTG(SCOTROC 4)和ANZGOG代表GCIG开展的研究。

Banerjee, S; Rustin, G; Paul, J; Williams, C; Pledge, S; Gabra, H; Skailes, G; Lamont, A; Hindley, A; Goss, G; Gilby, E; Hogg, M; Harper, P; Kipps, E; Lewsley, L-A; Hall, M; Vasey, P; Kaye, S B

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors

一项 I 期研究旨在确定双重 VEGFR 和 FGFR 抑制剂 brivanib 在晚期或转移性实体瘤患者中的安全性、药代动力学和药效学。

Jonker, D J; Rosen, L S; Sawyer, M B; de Braud, F; Wilding, G; Sweeney, C J; Jayson, G C; McArthur, G A; Rustin, G; Goss, G; Kantor, J; Velasquez, L; Syed, S; Mokliatchouk, O; Feltquate, D M; Kollia, G; Nuyten, D S A; Galbraith, S

A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer

CA4P(康布瑞他汀A-4磷酸盐)、卡铂和紫杉醇联合治疗晚期癌症患者的Ib期临床试验

Rustin, G J; Shreeves, G; Nathan, P D; Gaya, A; Ganesan, T S; Wang, D; Boxall, J; Poupard, L; Chaplin, D J; Stratford, M R L; Balkissoon, J; Zweifel, M

Relationship between human tumour angiogenic profile and combretastatin-induced vascular shutdown: an exploratory study.

人类肿瘤血管生成特征与康布瑞他汀诱导的血管关闭之间的关系:一项探索性研究

Gaya A, Daley F, Taylor N J, Tozer G, Qureshi U, Padhani A, Pedley R B, Begent R, Wellsted D, Stirling J J, Rustin G

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRI

动态磁共振成像测量铂类/紫杉烷类化疗对人盆腔肿瘤急性灌注的影响

Lankester, K J; Taylor, N J; Stirling, J J; Boxall, J; D'Arcy, J A; Leach, M O; Rustin, G J S; Padhani, A R